Bosch develops rapid test for COVID-19, diagnosis in under 2.5 hours
Bosch is helping medical facilities such as doctors’ offices, hospitals, laboratories, and health centers with its new COVID-19 rapid test.
The rapid test can diagnose ten respiratory pathogens simultaneously for differential diagnosis and meets the requirements of the World Health Organization (WHO). Reliable test results enable differential diagnosis in under 2.5 hours.
Bosch Healthcare Solutions, together with Randox Laboratories Ltd., has developed one of the world’s first fully automated molecular diagnostic tests.
Developed in just six weeks, the rapid test can detect a SARS-CoV-2 coronavirus infection in patients in under two and a half hours – measured from the time the sample is taken to the time the result arrives. Another advantage of the rapid test is that it can be performed directly at the point of care. This eliminates the need to transport samples, which takes up valuable time. It also means patients quickly gain certainty about their state of health, while allowing infected individuals to be identified and isolated immediately. With the tests currently in use, patients must usually wait one to two days for a result.